|
| |
Image Results
Loading...
Loading...
REMICADE Pages on BioPortfolio:
|
BioPortfolio - Decision Resources - Driven by Sales of Enbrel ...
Driven by Sales of Enbrel, Remicade and Humira ... 30 Apr 2009 . ... Remicade and Humira, spondyloarthropathies Drug Market Grew to Nearly $2 Billion in ...
http://www.bioportfolio.com/news/Driven_by_Sales_of_Enbrel,_...
|
Biotechnology News HUMIRA Search
TNF-alpha Inhibitors, Most Notably Humira and Remicade, Will Continue to Dominate the Crohn's Disease Drug Mar Continued Uptake of Humira Will be the ...
http://www.bioportfolio.co.uk/HUMIRA-news.htm...
|
BioPortfolio - Remicade - InDepth
Remicade. View the current Remicade InDepth page on BioPortfolio.com (PDF). ( http://www.bioportfolio.com/indepth/Remicade.html) - Regularly Updated. ...
http://www.bioportfolio.com/indepth/Remicade.pdf...
|
Biotechnology News Gastrointestinal Digestive Search
2 (Day News) -- Treatment with the drug infliximab (Remicade) reduced the need for surgery in patients by almost half, a new study found. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...
|
Biotech Tracker News - Lymphoma Risk for TNF Inhibitors
4 Mar 2003 ... We do not anticipate significant changes to our revenue models for Enbrel, Remicade, or Humira, at least until the relevant risks are better ...
http://www.bioportfolio.com/news/biotracker_74.htm...
|
Biotechnology News Arthritis Search
29, 2009 -- Rheumatoid arthritis patients who take the biologic drugs Remicade, Humira, and Enbrel do not appear... MedicineNet.com: Oct 30 2009 9:34PM ...
http://www.bioportfolio.co.uk/Arthritis-news.htm...
|
Emerging treatments for inflammatory bowel disease
In 2003, Centocor's Remicade (Infliximab) became first biologic to be approved by ... Remicade is a neutralizing anti-TNF alpha antibody approved for the ...
http://www.bioportfolio.com/news/DailyUpdates_73.htm...
| Results from other life science and pharmaceutical sites:
|